Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVD 38000: Responses to Vaccination With Typhoid and/or Cholera
NCT03705585Phase 4Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Nov 2018
- Primary completion
- May 2029
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of typhoid vaccine, live oral, cholera vaccine, live, oral in typhoid fever, cholera, sponsored by University of Maryland, Baltimore. Started Nov 2018; status: recruiting.
02
Drugs
typhoid vaccine, live oralcholera vaccine, live, oral
03
Conditions
typhoid fevercholera
Beyond the preview
Go deeper on NCT03705585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705585.